Zobrazeno 1 - 10
of 30
pro vyhledávání: '"V V Rybakova"'
Autor:
A S Avdeeva, M V Cherkasova, D A Kusevich, V V Rybakova, A S Artyuhov, Eh B Dashinimaev, N V Chichasova, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 91, Iss 5, Pp 26-33 (2019)
Aim: to evaluate the role of laboratory biomarkers in monitoring effectiveness of rituximab (RTM) biosimilar therapy in a total dose of 1200 mg. Materials and methods. 20 patients (pts) with rheumatoid arthritis (RA) (18 woman, mean age 61.5(54-66.5)
Externí odkaz:
https://doaj.org/article/c28b0e98ea46440eb5eb3cdfd06c3078
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 186-191 (2024)
The aim of the study was to investigate the relationship between cytokine levels and values of antibodies to cyclic citrullinated peptide (anti-CCP) and antibodies to carbamylated proteins (anti-CarP) in patients with rheumatoid arthritis (RA). Mater
Externí odkaz:
https://doaj.org/article/f524914255d047bf8baca2f4c1355b31
Autor:
A. S. Avdeeva, A. P. Aleksankin, Zh. G. Verizhnikova, V. V. Rybakova, M. E. Diatroptov, Yu. N. Gorbunova, A. A. Mesnyankina, D. A. Paranich, A. M. Lila, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 13-18 (2023)
Objective: To study the frequency of spontaneous foci of DNA double-strand breaks (DSBs) in patients with immune-inflammatory rheumatic diseases (IIRD), their relationship to disease activity, levels of inflammatory markers, and levels of autoantibod
Externí odkaz:
https://doaj.org/article/bbc5ebb2f0504a76a9c547ed2dc38b83
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 2, Pp 207-213 (2023)
The aim of the study was to study the features of the clinical picture of the disease in patients with ACPA-negative and ACPA-positive variants of rheumatoid arthritis.Materials and methods. The study included patients with a reliable diagnosis of rh
Externí odkaz:
https://doaj.org/article/5ebc5e669ce746bda799f439bd7dd45a
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 4, Pp 473-480 (2022)
Objective: to evaluate the role of monitoring the level of matrix metalloproteinase 3 (MMP-3) in patients with rheumatoid arthritis (RA) during anti-B-cell therapy.Material and methods. The study included 54 patients with a reliable diagnosis of RA.
Externí odkaz:
https://doaj.org/article/8dbf835b08b94e68a95fe42b1d76de8a
Publikováno v:
Современная ревматология, Vol 16, Iss 3, Pp 29-36 (2022)
Objective: to assess the relationship between laboratory biomarkers and ultrasonographic signs of inflammation in patients with rheumatoid arthritis during therapy with a rituximab (RTM) biosimilar.Patients and methods. 20 patients with definite diag
Externí odkaz:
https://doaj.org/article/ad5da39357394248b35c23e5ec62aa49
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 3, Pp 269-274 (2021)
Aim – to analyze long-term results of intensive treatment initiated at rheumatoid arthritis (RA) onset in real clinical practice.Material and methods. 93 RA patients were included. Subcutaneous MTX was initiated at 10–15 mg per week with further
Externí odkaz:
https://doaj.org/article/6e0b068a9ad8491c8fd3f968792609cd
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1 (2022)
The aim of the work – to research the relationship between the dynamics of cytokine levels in the early period (the first 12 and 24 weeks) of pharmacotherapy for rheumatoid arthritis (RA) and long-term outcomes in patients with the disease.Material
Externí odkaz:
https://doaj.org/article/1aba47c09ab342429754e754a8676379
Publikováno v:
Современная ревматология, Vol 14, Iss 2, Pp 27-34 (2020)
Objective: to study of the relationship between psychological factors and indicators of rheumatoid arthritis (RA) disease activity in patients who have been followed up for a long time after initiation of treat-to-target therapy.Patients and methods.
Externí odkaz:
https://doaj.org/article/5abd881dfcc74c80b6bcfe5a33858be0
Autor:
A. S. Avdeeva, A. M. Satybaldyev, N. V. Demidova, N. Yu. Nikishina, E. V. Gerasimova, N. V. Muravyeva, G. I. Gridneva, O. A. Rumyantseva, K. A. Kasumova, A. V. Alekseeva, N. V. Chichasova, D. A. Kusevich, V. V. Rybakova, E. A. Koshkarova, A. M. Lila, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 274-279 (2019)
Objective: to analyze therapy with rituximab (RTM) in real clinical practice according to the data available in OREL registry of patients with active rheumatoid arthritis (RA).Subjects and methods. The analysis included 349 patients. All the patients
Externí odkaz:
https://doaj.org/article/c83cabe4938a4829b645c10bcae3e0f2